Alumnus in focus: Malin Grape is the world's first AMR Ambassador
2022-03-28
“Sweden has a very distinctive voice in antibiotic matters that both the EU and the world listen to, and we must use it," states Malin Grape, Swedish ambassador against antimicrobial resistance and alumnus at the Faculty of Pharmacy.

Thursday 20 January this year, medical journal The Lancet published a study that estimated that 1.3 million people died in 2019 as a result of infections caused by resistant bacteria. This makes antimicrobial resistance (AMR) one of the world's most common causes of death, and just weeks after the publication, the government announced that Sweden, as the first country in the world, had appointed an AMR Ambassador.
“Everything happened very fast. I was offered the position during a telephone conversation with the Secretary of State, and even though it comes with great challenges, the content aligns so precisely with my experiences and interests that I accepted without hesitation. Now I have eighteen months to fulfil all the expectations and goals that come with the role, and it is definitely a task that inspires,” states Malin Grape from her new office at the Ministry of Social Affairs.
It is not entirely surprising that Sweden is leading the way with an ambassador to strengthen global protection against antibiotic resistance. Already early on, our country began a long-term work in the field; In 1986, we launched the world's first ban on providing animals antibiotics for growth-promoting purposes, and today we have, in a global comparison, an overall low antibiotic consumption. Sweden also lead several internationally important initiatives, not least the Uppsala coordinated ReAct and newly initiated ENABLE-2.

“These are two very good examples of how we must work to handle the complex challenges antimicrobial resistance presents us with. ENABLE-2 provides important support in the development of new antibiotics, which is absolutely necessary. ReAct has a strong role in pursuing policy issues at a global level, not least to provide low-resource countries with the conditions required to reverse the trend. In fact, Sweden has a very distinctive voice in antibiotic matters that both the EU and the world listen to, and we must use it.”
Malin Grape brings extensive experience of international collaboration to her new position. During eight years as Head of the Swedish Public Health Agency's Unit for Antibiotics and Care Hygiene, she was in charge of the development of the World Health Organization's global monitoring system for antibiotic resistance, GLASS, and also had a central position in the pan-European initiative Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections, JAMRAI.
“In my role at the Public Health Agency, my professional network reached all over the world and in some of previous assignments I often worked onsite. As an AMR ambassador, an international perspective is necessary, and I am currently preparing, among many things, our activities during the forthcoming World Health Assembly in Geneva and next year's Swedish EU Presidency, where antimicrobial resistance will be high on the agenda.”
As the world's first, and so far only, AMR ambassador, it is also included to fine-tune your own working day. The attention surrounding the position is massive and the arenas many, which makes wise priorities necessary. In parallel with establishing herself within the Ministry of Social Affairs and reporting to its political leadership, strategic ties have to be established. Malin’s current schedule includes everything from interviews with the media and conversations with the British Envoy against antimicrobial resistance to an audience at the castle.
“I received a request for a meeting with Crown Princess Victoria to present our ongoing work, which is something I am more than happy to set aside time for. It was a very good conversation where the Crown Princess showed great interest and was well acquainted with the challenges. My work is simply very exciting, and it is fascinating to see how the knowledge and interest in antibiotics I founded during my pharmacy education at Uppsala University now comes in great and daily use!”
Facts: Malin Grape
- Education Pharmacy degree at Uppsala University 2001, Doctoral degree Karolinska Institutet 2006
- Profession Sweden's AMR Ambassador, Ministry of Social Affairs
- Currently The world's first and so far only ambassador against antimicrobial resistance
MORE ALUMNUS IN FOCUS
- Joachim Gullbo's PhD-project turns into new cancer treatment
- Erik Fredholm, vaccine coordinator in Region Örebro
MORE INFORMATION
- Alumnföreningen Farmis (in Swedish)
- Farmacevtiska Studentkåren (in Swedish)
text: Magnus Alsne, photo: Lena Katarina Johansson
ENABLE-2 News and media coverage
-
ENABLE-2 expanding its project portfolio with two new programmes
2023-09-18
Antibiotic platform ENABLE-2 welcomes two new programmes: the "Ornicidine" programme, a scientific collaboration between Leiden University in the Netherlands and Queen's University Belfast in Northern Ireland; and the "BamA Inhibitors" programme, based at the German Justus Liebig University Giessen and Fraunhofer IME.
-
ENABLE-2 crosses the North Sea
2023-06-10
ENABLE-2 expands its project portfolio with Strathclyde Minor Groove Binders, a program based in Glasgow and the University of Strathclyde. With this collaboration, the platform takes the step into Europe in its search for new promising antibiotics.
-
ENABLE-2 Open Call raising international interest
2023-01-18
“We welcome the great international interest shown in our platform", states Anders Karlén, coordinator of ENABLE-2 that in a recent call for proposals received applications from six European countries.
-
Läkemedelsvärlden: Enable-2 får fortsatt finansiering 2023
2022-12-20
Läkemedelsvärlden, 2022-12-20
-
Anders Karlén in Lif podcast: Antibiotic resistance - the silent pandemic
2022-12-19
Anders Karlén, Professor of Computational Medicinal Chemistry and coordinator of ENABLE 2, and Årets läkemedelsprofil (Pharmaceutical Drug Profile of the Year) Enrico Baraldi discuss Antibiotic resistance - the silent pandemic in a new episode of Lif:s Podden. Antibiotic expert Bengt Mattson and Pod host Amy Havenäng, both Lif, also participate in the conversation (note: pod in Swedish)
-
The Swedish Research Council invests SEK 25 million in ENABLE-2
2022-12-13
ENABLE-2 receives continued funding from the Swedish Research Council, now allocating SEK 25 million to the platform's second year of operations. "We are about to open a second call in order to complement our portfolio with additional projects," says Anders Karlén, Coordinator of ENABLE-2 and Professor at Uppsala University.
-
ENABLE-2 partner Uppsala University publishes patent application
2022-12-05
ENABLE-2 partner Uppsala University has published a first patent application on a series of compounds targeting the LpxH enzyme and showing highly potent in vivo activity. These compounds are active against wild-type bacterial cells, including carbapenem-resistant clinical isolates, and show very good efficacy in clearing infections in mouse models.
-
Anders Karlén guest in Forskarpodden: The Fight Against Antibiotic Resistance
2022-11-22
In The Fight against Antibiotic Resistance, the new episode of Forskarpodden, Anders Karlén, Professor and Coordinator of ENABLE-2, and Dan I Andersson, Professor of Medical Bacteriology, discuss the current efforts at Uppsala University to fight the challenges of accelerating antibiotic resistance. (Note: Pod in Swedish)
-
Akut behov av breda lösningar mot antibiotikaresistens
2022-11-16
Vinnova.2022-11-16
-
Luke Odell promoted to Professor of Medicinal Chemistry
2022-11-14
ENABLE-2 and The Faculty of Pharmacy congratulates Luke Odell on his promotion to Professor of Medicinal Chemistry at Uppsala University. “Research is a joint effort, so this is a recognition that our entire team can take pride in,” states Luke Odell, leader of ENABLE-2 project QuinGiT.
-
ENABLE-2 has accepted a new program from Thioredoxin Systems AB
2022-09-30
We are happy to announce that ENABLE-2 has accepted a new program to assist Thioredoxin Systems AB in the development of their EbsArgent product.
-
Researcher profile: Anders Karlén coordinates the combat against the invisible enemy
2022-06-11
“As long as disaster does not strike with full force, many prefer to look elsewhere,” says Anders Karlén, Professor of Computer-Aided Drug Design, who after coordinating the European flagship ENABLE now continues the fight against antibiotic-resistant bacteria within the framework of the international platform ENABLE -2.
-
”Morötter till industrin löser inte bristen på nya antibiotika”
2022-05-23
Dagens Medicin, 2022-05-23
-
ENABLE-2 satsar på fyra projekt om nya antibiotika
2022-03-29
LäkemedelsVärlden, 2022-03-29
-
Alumnus in focus: Malin Grape is the world's first AMR Ambassador
2022-03-28
“Sweden has a very distinctive voice in antibiotic matters that both the EU and the world listen to, and we must use it," states Malin Grape, Swedish ambassador against antimicrobial resistance and alumnus at the Faculty of Pharmacy.
-
QureTech Bio får stort stöd för fortsatt utveckling av nya antibiotika
2022-03-23
Umeåbaserade QureTech Bio AB får stöd av Vetenskapsrådets storsatsning ENABLE-2, som i samarbete med Vinnova även ger små och medelstora företag tillgång till ENABLE-2-plattformen för att fortsätta jakten på nya antibiotika. Plattformen tillhandhåller resurser i form av experimentellt arbete och erfarenhet inom antibiotikautvecklingens tidiga stadier.
-
ENABLE-2 takes the lead in the pursuit of new antibiotics
2022-03-21
The Swedish Research Council's investment in ENABLE-2 has, with support from Vinnova, launched with four projects that are considered very promising in the pursuit for new antibiotics. In the first round of admissions, two projects from Uppsala University, and one each from Linköping University and the biotech company QureTech Bio AB were selected for development.
-
ENABLE-2 ready to lead continued development of new antibiotics
2021-12-21
ENABLE, the EU initiative for antibiotic development led by Uppsala University, will continue its work in ENABLE-2 with financial support from the Swedish Research Council. "An independent committee have chosen between many interesting project proposals and the platform is now entering operational phase," says Anders Karlén, Professor at the Faculty of Pharmacy.
-
SciLifeLab part of ENABLE-2, an international collaboration to combat antimicrobial resistance
2021-10-18
SciLifeLab, 2021-10-18
-
Forskningspengar att söka för nya antibiotika
2021-10-07
LäkemedelsVärlden, 2021-10-07
-
SEK 25 million to ENABLE-2 and continued development of new antibiotics
2021-10-05
ENABLE, the EU initiative for antibiotic development led by Uppsala University, has received SEK 25 million from the Swedish Research Council to start up ENABLE-2. "We are already accepting project proposals and hope that this investment will inspire more financiers," says coordinator Anders Karlén.
-
Nya pengar till svenskledd satsning på nya antibiotika
2021-03-10
LäkemedelsVärlden, 2021-03-10
Learn more about current & previous events at ENABLE-2